Antiretroviral restriction factors

Current Opinion in Virology

Volumn 1, Issue 6, 2011, Pages 526-532

  Hatziioannou, Theodora ^a   Bieniasz, Paul D ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN APOBEC3; PROTEIN SAMHD1; PROTEIN TRIM28; PROTEIN ZFP809; TETHERIN; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; VIRUS PROTEIN; ZINC FINGER PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RETROVIRUS; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 82955178663     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2011.10.007     Document Type: Review

References (85)

1. A.M. Sheehy, N.C. Gaddis, J.D. Choi, and M.H. Malim Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 418 2002 646 650
2. S.G. Conticello, C.J. Thomas, S.K. Petersen-Mahrt, and M.S. Neuberger Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases Mol Biol Evol 22 2005 367 377 (Pubitemid 40130201)
3. S.L. Sawyer, M. Emerman, and H.S. Malik Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G PLoS Biol 2 2004 E275
4. Y.L. Chiu, and W.C. Greene The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements Annu Rev Immunol 26 2008 317 353 (Pubitemid 351600379)
5. A. Schafer, H.P. Bogerd, and B.R. Cullen Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor Virology 328 2004 163 168 (Pubitemid 39349465)
6. E.S. Svarovskaia, H. Xu, J.L. Mbisa, R. Barr, R.J. Gorelick, A. Ono, E.O. Freed, W.S. Hu, and V.K. Pathak Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs J Biol Chem 279 2004 35822 35828 (Pubitemid 39100589)
7. V. Zennou, D. Perez-Caballero, H. Gottlinger, and P.D. Bieniasz APOBEC3G incorporation into human immunodeficiency virus type 1 particles J Virol 78 2004 12058 12061 (Pubitemid 39390791)
8. R.S. Harris, K.N. Bishop, A.M. Sheehy, H.M. Craig, S.K. Petersen-Mahrt, I.N. Watt, M.S. Neuberger, and M.H. Malim DNA deamination mediates innate immunity to retroviral infection Cell 113 2003 803 809 (Pubitemid 36724943)
9. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424 2003 99 103 (Pubitemid 36834849)
10. Q. Yu, R. Konig, S. Pillai, K. Chiles, M. Kearney, S. Palmer, D. Richman, J.M. Coffin, and N.R. Landau Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome Nat Struct Mol Biol 11 2004 435 442 (Pubitemid 38568947)
11. H. Zhang, B. Yang, R.J. Pomerantz, C. Zhang, S.C. Arunachalam, and L. Gao The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Nature 424 2003 94 98 (Pubitemid 36834848)
12. E.N. Newman, R.K. Holmes, H.M. Craig, K.C. Klein, J.R. Lingappa, M.H. Malim, and A.M. Sheehy Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity Curr Biol 15 2005 166 170
13. M. Marin, K.M. Rose, S.L. Kozak, and D. Kabat HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat Med 9 2003 1398 1403 (Pubitemid 37466189)
14. A. Mehle, B. Strack, P. Ancuta, C. Zhang, M. McPike, and D. Gabuzda Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway J Biol Chem 279 2004 7792 7798 (Pubitemid 38294663)
15. A.M. Sheehy, N.C. Gaddis, and M.H. Malim The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat Med 9 2003 1404 1407 (Pubitemid 37466190)
16. X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.F. Yu Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 302 2003 1056 1060 (Pubitemid 37386201)
17. R. Mariani, D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N.R. Landau Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 114 2003 21 31 (Pubitemid 36859838)
18. C.A. Virgen, and T. Hatziioannou Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins J Virol 81 2007 13932 13937 (Pubitemid 350247887)
19. M. Stremlau, C.M. Owens, M.J. Perron, M. Kiessling, P. Autissier, and J. Sodroski The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys Nature 427 2004 848 853 (Pubitemid 38297747)
20. S. Sebastian, and J. Luban TRIM5alpha selectively binds a restriction-sensitive retroviral capsid Retrovirology 2 2005 40
21. M. Stremlau, M. Perron, M. Lee, Y. Li, B. Song, H. Javanbakht, F. Diaz-Griffero, D.J. Anderson, W.I. Sundquist, and J. Sodroski Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor Proc Natl Acad Sci USA 103 2006 5514 5519
22. T. Hatziioannou, D. Perez-Caballero, A. Yang, S. Cowan, and P.D. Bieniasz Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha Proc Natl Acad Sci USA 101 2004 10774 10779 (Pubitemid 38955818)
23. Z. Keckesova, L.M. Ylinen, and G.J. Towers The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities Proc Natl Acad Sci USA 101 2004 10780 10785 (Pubitemid 38955819)
24. M.J. Perron, M. Stremlau, B. Song, W. Ulm, R.C. Mulligan, and J. Sodroski TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells Proc Natl Acad Sci USA 101 2004 11827 11832 (Pubitemid 39095379)
25. M.W. Yap, S. Nisole, C. Lynch, and J.P. Stoye Trim5alpha protein restricts both HIV-1 and murine leukemia virus Proc Natl Acad Sci USA 101 2004 10786 10791 (Pubitemid 38955820)
26. S. Nisole, C. Lynch, J.P. Stoye, and M.W. Yap A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1 Proc Natl Acad Sci USA 101 2004 13324 13328 (Pubitemid 39209664)
27. D.M. Sayah, E. Sokolskaja, L. Berthoux, and J. Luban Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1 Nature 430 2004 569 573 (Pubitemid 38998631)
28. C.H. Liao, Y.Q. Kuang, H.L. Liu, Y.T. Zheng, and B. Su A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection AIDS 21 Suppl. 8 2007 S19 S26
29. G. Brennan, Y. Kozyrev, and S.-L. Hu TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis Proc Natl Acad Sci USA 2008 10.1073/pnas.0709258105 (Pubitemid 351723592)
30. R.M. Newman, L. Hall, A. Kirmaier, L.A. Pozzi, E. Pery, M. Farzan, S.P. O'Neil, and W. Johnson Evolution of a TRIM5-CypA splice isoform in old world monkeys PLoS Pathog 4 2008 e1000003
31. C.V. Virgen, Z. Kratovac, P.D. Bieniasz, and T. Hatziioannou Independent genesis of chimeric TRIM-cyclophilin proteins in two primate species Proc Natl Acad Sci USA 2008 10.1073/pnas.0709258105 (Pubitemid 351723592)
32. S.J. Wilson, B.L.J. Webb, L.M.J. Ylinen, E. Verschoor, J.L. Heeney, and G.J. Towers Independent evolution of an antiviral TRIMCyp in rhesus macaques Proc Natl Acad Sci USA 2008 10.1073/pnas.0709258105 (Pubitemid 351723592)
33. D.C. Goldstone, M.W. Yap, L.E. Robertson, L.F. Haire, W.R. Taylor, A. Katzourakis, J.P. Stoye, and I.A. Taylor Structural and functional analysis of prehistoric lentiviruses uncovers an ancient molecular interface Cell Host Microbe 8 2010 248 259
34. H. Javanbakht, F. Diaz-Griffero, M. Stremlau, Z. Si, and J. Sodroski The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha J Biol Chem 280 2005 26933 26940 (Pubitemid 41040729)
35. D. Perez-Caballero, T. Hatziioannou, A. Yang, S. Cowan, and P.D. Bieniasz Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity J Virol 79 2005 8969 8978 (Pubitemid 40934808)
36. D. Perez-Caballero, T. Hatziioannou, F. Zhang, S. Cowan, and P.D. Bieniasz Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity J Virol 79 2005 15567 15572 (Pubitemid 43032338)
37. X. Wu, J.L. Anderson, E.M. Campbell, A.M. Joseph, and T.J. Hope Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection Proc Natl Acad Sci USA 103 2006 7465 7470 (Pubitemid 43727856)
38. F. Diaz-Griffero, X.R. Qin, F. Hayashi, T. Kigawa, A. Finzi, Z. Sarnak, M. Lienlaf, S. Yokoyama, and J. Sodroski A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction J Virol 83 2009 10737 10751
39. H. Javanbakht, W. Yuan, D.F. Yeung, B. Song, F. Diaz-Griffero, Y. Li, X. Li, M. Stremlau, and J. Sodroski Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding Virology 353 2006 234 246 (Pubitemid 44308489)
40. X. Li, and J. Sodroski The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association J Virol 82 2008 11495 11502
41. B.K. Ganser-Pornillos, V. Chandrasekaran, O. Pornillos, J.G. Sodroski, W.I. Sundquist, and M. Yeager Hexagonal assembly of a restricting TRIM5alpha protein Proc Natl Acad Sci USA 108 2011 534 539
42. T. Pertel, S. Hausmann, D. Morger, S. Zuger, J. Guerra, J. Lascano, C. Reinhard, F.A. Santoni, P.D. Uchil, and L. Chatel TRIM5 is an innate immune sensor for the retrovirus capsid lattice Nature 472 2011 361 365
43. D. Wolf, and S.P. Goff TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells Cell 131 2007 46 57 (Pubitemid 47498526)
44. D. Wolf, and S.P. Goff Embryonic stem cells use ZFP809 to silence retroviral DNAs Nature 458 2009 1201 1204
45. D. Wolf, K. Hug, and S.P. Goff TRIM28 mediates primer binding site-targeted silencing of Lys1,2 tRNA-utilizing retroviruses in embryonic cells Proc Natl Acad Sci USA 105 2008 12521 12526
46. H.M. Rowe, J. Jakobsson, D. Mesnard, J. Rougemont, S. Reynard, T. Aktas, P.V. Maillard, H. Layard-Liesching, S. Verp, and J. Marquis KAP1 controls endogenous retroviruses in embryonic stem cells Nature 463 2010 237 240
47. S.J. Neil, T. Zang, and P.D. Bieniasz Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu Nature 451 2008 425 430 (Pubitemid 351158893)
48. N. Van Damme, D. Goff, C. Katsura, R.L. Jorgenson, R. Mitchell, M.C. Johnson, E.B. Stephens, and J. Guatelli The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein Cell Host Microbe 3 2008 245 252 (Pubitemid 351494713)
49. A. Hinz, N. Miguet, G. Natrajan, Y. Usami, H. Yamanaka, P. Renesto, B. Hartlieb, A.A. McCarthy, J.P. Simorre, and H. Gottlinger Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain Cell Host Microbe 7 2010 314 323
50. H. Yang, J. Wang, X. Jia, M.W. McNatt, T. Zang, B. Pan, W. Meng, H.W. Wang, P.D. Bieniasz, and Y. Xiong Structural insight into the mechanisms of enveloped virus tethering by tetherin Proc Natl Acad Sci USA 107 2010 18428 18432
51. H.L. Schubert, Q. Zhai, V. Sandrin, D.M. Eckert, M. Garcia-Maya, L. Saul, W.I. Sundquist, R.A. Steiner, and C.P. Hill Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations Proc Natl Acad Sci USA 107 2010 17951 17956
52. D. Perez-Caballero, T. Zang, A. Ebrahimi, M.W. McNatt, D.A. Gregory, M.C. Johnson, and P.D. Bieniasz Tetherin inhibits HIV-1 release by directly tethering virions to cells Cell 139 2009 499 511
53. K. Fitzpatrick, M. Skasko, T.J. Deerinck, J. Crum, M.H. Ellisman, and J. Guatelli Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles PLoS Pathog 6 2010 e1000701
54. J. Hammonds, J.J. Wang, H. Yi, and P. Spearman Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane PLoS Pathog 6 2010 e1000749
55. N. Jouvenet, S.J. Neil, M. Zhadina, T. Zang, Z. Kratovac, Y. Lee, M. McNatt, T. Hatziioannou, and P.D. Bieniasz Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin J Virol 83 2009 1837 1844
56. T. Sakuma, T. Noda, S. Urata, Y. Kawaoka, and J. Yasuda Inhibition of Lassa and Marburg virus production by tetherin J Virol 83 2009 2382 2385
57. R.L. Kaletsky, J.R. Francica, C. Agrawal-Gamse, and P. Bates Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein Proc Natl Acad Sci USA 106 2009 2886 2891
58. C. Pardieu, R. Vigan, S.J. Wilson, A. Calvi, T. Zang, P. Bieniasz, P. Kellam, G.J. Towers, and S.J. Neil The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin PLoS Pathog 6 2010 e1000843
59. F. Zhang, S.J. Wilson, W.C. Landford, B. Virgen, D. Gregory, M.C. Johnson, J. Munch, F. Kirchhoff, P.D. Bieniasz, and T. Hatziioannou Nef proteins from simian immunodeficiency viruses are tetherin antagonists Cell Host Microbe 6 2009 54 67
60. B. Jia, R. Serra-Moreno, W. Neidermyer, A. Rahmberg, J. Mackey, I.B. Fofana, W.E. Johnson, S. Westmoreland, and D.T. Evans Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2 PLoS Pathog 5 2009 e1000429
61. M. Dube, B.B. Roy, P. Guiot-Guillain, J. Binette, J. Mercier, A. Chiasson, and E.A. Cohen Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment PLoS Pathog 6 2010 e1000856
62. D. Lau, W. Kwan, and J. Guatelli Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens J Virol 85 2011 9834 9846
63. M. Skasko, A. Tokarev, C.C. Chen, W.B. Fischer, S.K. Pillai, and J. Guatelli BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action Virology 411 2011 65 77
64. E. Bartee, A. McCormack, and K. Fruh Quantitative membrane proteomics reveals new cellular targets of viral immune modulators PLoS Pathog 2 2006 e107
65. F. Zhang, W.N. Landford, M. Ng, M.W. McNatt, P.D. Bieniasz, and T. Hatziioannou SIV Nef proteins recruit the AP-2 complex to antagonize Tetherin and facilitate virion release PLoS Pathog 7 2011 e1002039
66. A. Le Tortorec, and S.J. Neil Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein J Virol 83 2009 11966 11978
67. R.K. Gupta, P. Mlcochova, A. Pelchen-Matthews, S.J. Petit, G. Mattiuzzo, D. Pillay, Y. Takeuchi, M. Marsh, and G.J. Towers Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration Proc Natl Acad Sci USA 106 2009 20889 20894
68. M.W. McNatt, T. Zang, T. Hatziioannou, M. Bartlett, I.B. Fofana, W.E. Johnson, S.J. Neil, and P.D. Bieniasz Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants PLoS Pathog 5 2009 e1000300
69. R.K. Gupta, S. Hue, T. Schaller, E. Verschoor, D. Pillay, and G.J. Towers Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion PLoS Pathog 5 2009 e1000443
70. D. Sauter, M. Schindler, A. Specht, W.N. Landford, J. Munch, K.A. Kim, J. Votteler, U. Schubert, F. Bibollet-Ruche, and B.F. Keele Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains Cell Host Microbe 6 2009 409 421
71. N. Sharova, Y. Wu, X. Zhu, R. Stranska, R. Kaushik, M. Sharkey, and M. Stevenson Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction PLoS Pathog 4 2008 e1000057
72. S. Srivastava, S.K. Swanson, N. Manel, L. Florens, M.P. Washburn, and J. Skowronski Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection PLoS Pathog 4 2008 e1000059
73. C. Goujon, L. Riviere, L. Jarrosson-Wuilleme, J. Bernaud, D. Rigal, J.L. Darlix, and A. Cimarelli SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells Retrovirology 4 2007 2
74. T. Pertel, C. Reinhard, and J. Luban Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon Retrovirology 8 2011 49
75. K. Hrecka, C. Hao, M. Gierszewska, S.K. Swanson, M. Kesik-Brodacka, S. Srivastava, L. Florens, M.P. Washburn, and J. Skowronski Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein Nature 474 2011 658 661
76. N. Laguette, B. Sobhian, N. Casartelli, M. Ringeard, C. Chable-Bessia, E. Segeral, A. Yatim, S. Emiliani, O. Schwartz, and M. Benkirane SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx Nature 474 2011 654 657
77. G. Gao, X. Guo, and S.P. Goff Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein Science 297 2002 1703 1706 (Pubitemid 35000785)
78. M.J. Bick, J.W. Carroll, G. Gao, S.P. Goff, C.M. Rice, and M.R. MacDonald Expression of the zinc-finger antiviral protein inhibits alphavirus replication J Virol 77 2003 11555 11562 (Pubitemid 37271654)
79. X. Guo, J.W. Carroll, M.R. Macdonald, S.P. Goff, and G. Gao The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs J Virol 78 2004 12781 12787 (Pubitemid 39507786)
80. M.H. Naghavi, T. Hatziioannou, G. Gao, and S.P. Goff Overexpression of fasciculation and elongation protein zeta-1 (FEZ1) induces a post-entry block to retroviruses in cultured cells Genes Dev 19 2005 1105 1115 (Pubitemid 40632455)
81. S.L. Kozak, M. Marin, K.M. Rose, C. Bystrom, and D. Kabat The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules J Biol Chem 281 2006 29105 29119 (Pubitemid 44507054)
82. V. Furtak, A. Mulky, S.A. Rawlings, L. Kozhaya, K. Lee, V.N. Kewalramani, and D. Unutmaz Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity PLoS ONE 5 2010 e9081
83. X. Wang, Y. Han, Y. Dang, W. Fu, T. Zhou, R.G. Ptak, and Y.H. Zheng Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication J Biol Chem 285 2010 14346 14355
84. R. Burdick, J.L. Smith, C. Chaipan, Y. Friew, J. Chen, N.J. Venkatachari, K.A. Delviks-Frankenberry, W.S. Hu, and V.K. Pathak P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages J Virol 84 2010 10241 10253
85. D. Haussecker, D. Cao, Y. Huang, P. Parameswaran, A.Z. Fire, and M.A. Kay Capped small RNAs and MOV10 in human hepatitis delta virus replication Nat Struct Mol Biol 15 2008 714 721 (Pubitemid 351932001)